Analysis Article • Apr 20
Have your own idea? Try our Stock Screener
Singaporean (SGX) Healthcare Sector Analysis
UpdatedJun 30, 2026
DataAggregated Company Financials
Companies29
- 7D-1.8%
- 3M-1.1%
- 1Y24.9%
- YTD-6.6%
Over the last 7 days, the Healthcare industry has dropped 1.8%, driven by a pullback from UltraGreen.ai of 6.7%. This takes the industry's 12 month performance to a gain of 25%. Earnings are forecast to grow by 25% annually.
Sector Valuation and Performance
Has the Singaporean Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 30 Jun 2026 | S$11.5b | S$3.2b | S$342.4m | 19.6x | 33.6x | 3.6x |
| Thu, 28 May 2026 | S$12.0b | S$3.2b | S$343.2m | 17.2x | 34.9x | 3.7x |
| Sat, 25 Apr 2026 | S$12.2b | S$3.2b | S$348.6m | 17.7x | 34.9x | 3.8x |
| Mon, 23 Mar 2026 | S$11.6b | S$3.2b | S$352.8m | 16.1x | 33x | 3.6x |
| Wed, 18 Feb 2026 | S$10.3b | S$3.1b | S$292.6m | 15.8x | 35.3x | 3.3x |
| Fri, 16 Jan 2026 | S$10.3b | S$3.1b | S$296.3m | 14.6x | 34.6x | 3.3x |
| Sun, 14 Dec 2025 | S$9.7b | S$3.1b | S$295.2m | 15.1x | 32.8x | 3.1x |
| Tue, 11 Nov 2025 | S$9.6b | S$3.1b | S$301.0m | 15.1x | 31.8x | 3.1x |
| Thu, 09 Oct 2025 | S$9.4b | S$3.1b | S$306.6m | 16.4x | 30.6x | 3x |
| Sat, 06 Sep 2025 | S$9.8b | S$3.2b | S$350.9m | 15.5x | 28.1x | 3.1x |
| Mon, 04 Aug 2025 | S$9.3b | S$3.1b | S$371.5m | 13.5x | 25.1x | 3.1x |
| Wed, 02 Jul 2025 | S$8.8b | S$3.1b | S$372.9m | 12.3x | 23.5x | 2.8x |
| Fri, 30 May 2025 | S$8.6b | S$3.1b | S$368.5m | 12.5x | 23.3x | 2.8x |
| Sun, 27 Apr 2025 | S$9.0b | S$3.1b | S$371.8m | 12.3x | 24.1x | 2.9x |
| Tue, 25 Mar 2025 | S$9.2b | S$3.1b | S$373.0m | 12.6x | 24.7x | 3x |
| Thu, 20 Feb 2025 | S$8.7b | S$3.0b | S$348.3m | 16.2x | 25.1x | 2.9x |
| Sat, 18 Jan 2025 | S$8.7b | S$3.0b | S$349.8m | 16.5x | 25x | 2.9x |
| Mon, 16 Dec 2024 | S$8.8b | S$3.0b | S$350.2m | 16.5x | 25.2x | 3x |
| Wed, 13 Nov 2024 | S$8.6b | S$3.0b | S$344.5m | 16x | 25x | 2.9x |
| Fri, 11 Oct 2024 | S$8.6b | S$2.9b | S$360.0m | 16.3x | 23.9x | 2.9x |
| Sun, 08 Sep 2024 | S$8.4b | S$3.0b | S$362.2m | 16.5x | 23.3x | 2.8x |
| Tue, 06 Aug 2024 | S$8.3b | S$2.9b | S$334.9m | 17.5x | 24.8x | 2.9x |
| Thu, 04 Jul 2024 | S$8.7b | S$2.9b | S$364.4m | 16.9x | 23.8x | 3x |
| Sat, 01 Jun 2024 | S$8.6b | S$2.9b | S$368.2m | 16.4x | 23.4x | 3x |
| Mon, 29 Apr 2024 | S$8.4b | S$2.9b | S$357.6m | 16x | 23.5x | 2.9x |
| Wed, 27 Mar 2024 | S$8.5b | S$2.9b | S$411.8m | 14.2x | 20.6x | 2.9x |
| Fri, 23 Feb 2024 | S$8.5b | S$2.9b | S$359.9m | 14x | 23.6x | 3x |
| Sun, 21 Jan 2024 | S$9.0b | S$3.2b | S$441.7m | 14.8x | 20.3x | 2.8x |
| Tue, 19 Dec 2023 | S$9.4b | S$3.2b | S$440.5m | 15.7x | 21.4x | 3x |
| Thu, 16 Nov 2023 | S$11.7b | S$4.4b | S$580.2m | 15.8x | 20.2x | 2.7x |
| Sat, 14 Oct 2023 | S$12.3b | S$4.4b | S$595.8m | 15.9x | 20.6x | 2.8x |
| Mon, 11 Sep 2023 | S$12.5b | S$4.4b | S$597.6m | 16.1x | 21x | 2.9x |
| Wed, 09 Aug 2023 | S$13.4b | S$4.4b | S$627.4m | 16x | 21.3x | 3x |
| Fri, 07 Jul 2023 | S$13.3b | S$4.5b | S$646.3m | 16x | 20.6x | 3x |
Price to Earnings Ratio
20.6x
Current Industry PE
- Investors are optimistic on the Singaporean Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 33.6x which is higher than its 3-year average PE of 25.8x.
- The 3-year average PS ratio of 3.0x is lower than the industry's current PS ratio of 3.6x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 19% per year over the last three years,
- Revenues have also declined 10% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the Singaporean Healthcare sector?
| SG Market | -0.27% | |
| Healthcare | -1.81% | |
| Pharma | 0.51% | |
| Medical Equipment | -2.92% | |
| Healthcare Services | -3.02% | |
Industry PE
- Investors are most optimistic about the Medical Equipment industry which is trading above its 3-year average PE ratio.
- Analysts are expecting annual earnings growth of 18.7%, which is higher than its past year's earnings decline of 18.8% per year.
Forecasted Growth
- Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 49% over the next 5 years.
- This is better than its past earnings decline of 9.3% per year.
- In contrast, the Pharma industry is expected to see its earnings grow by 4.1% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| AP4 Riverstone Holdings | S$0.85 | 2.4% +S$29.6m | 26.7% | PE20.8x | |
| 5WA OUE Healthcare | S$0.038 | 8.6% +S$13.3m | 52.0% | PS1.1x | |
| 1D4 Aoxin Q & M Dental Group | S$0.24 | 4.3% +S$11.6m | 456.8% | PE213.3x | |
| 9G2 Singapore Institute of Advanced Medicine Holdings | S$0.03 | -14.3% S$8.6m | 3.5% | PS3.2x | |
| 1H3 Clearbridge Health | S$0.002 | 100.0% +S$6.4m | -33.3% | PS1.3x |